Purpose Rheumatoid arthritis (RA) is associated with a higher risk of diabetes mellitus (DM). Our aim was to determine associations between inflammatory disease activity (including evaluation of ...
Background The SRI(4) is a composite endpoint used in SLE clinical trials. A post-hoc analysis of two Phase III studies of belimumab 1 showed that the achievement of an SRI(4) response at 52 weeks is ...
Objectives To update the 2017 European Alliance of Associations for Rheumatology (EULAR) recommendations for treatment of systemic sclerosis (SSc), incorporating new evidence and therapies. Methods An ...
Objectives The dynamics of monosodium urate (MSU) crystal changes across a range of serum urate concentrations in people with gout are unknown. This study aimed to systematically examine the ...
We read with great interest the article by Zhu et al .1 It was based on a national study regarding the association between idiopathic thrombocytopenic purpura (ITP) and the subsequent development of ...
Objective Varus and valgus alignment increase medial and lateral tibiofemoral load. Alignment was associated with tibiofemoral osteoarthritis progression in previous studies; an effect on incident ...
© BMJ Publishing Group Ltd. All rights, including for text and data mining, AI training, and similar technologies, are reserved.
F8: Back to the future: how to mix the old and new treatments for SLE, Sjögren's and APS ...
Objectives Knee osteoarthritis (KOA) is a leading cause of global disability with conventional exercise yielding only modest improvements. Here we aimed to investigate the benefits of integrating ...
‘Poly-refractory’ disease affects 2.7% of patients with rheumatoid arthritis (RA) who have failed different groups of biologic disease-modifying antirheumatic drugs (b-DMARDS) and targeted synthetic ...
We read with interest the recent article by Singh and Cleveland on the hypersensitivity risk of allopurinol (ALP) and febuxostat (FBX) compared with colchicine.1 A common challenge when using ALP, ...
Background Apoptosis eliminates auto-reactive T and B cells during immune responses; failure of elimination is important in development of systemic lupus erythematosus (SLE). Elevated Bcl-2 expression ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results